Drugs / DBI UC-MSC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07449364 | Mar → Dec 2025 | — | Daewoong Group Indonesia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DBI UC-MSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07449364 ↗ |
| Modality | Cell therapy | “Umbilical Cord-derived Mesenchymal Stem Cell” NCT07449364 ↗ |
| Route | Intravenous | “administered to the subjects via Intravenous (IV) infusion” NCT07449364 ↗ |